Biotech stories
New Relic has been named a Leader in the Gartner Magic Quadrant for Observability Platforms, continuing its unmatched streak since 2012.
Superlab Suisse opens the largest private lab in Switzerland at Basel's Stcki Park, boosting support for life science and biotech startups with state-of-the-art facilities.
Capgemini's new report reveals a six-fold surge in connected health solutions in pharma and biotech since 2021, with organisations expecting 20% of revenue from these services within five years.
Reveille Software partners with Court Square Group to optimise user experience and efficiency for the life science industry software, RegDocs365, aiming to reduce downtime and swiftly resolve content-related issues.
On International Women's Day 2024, women strive for equality in STEM fields, overcoming difficulties, and advocating for their teams, with data indicating a growing desire for career progression.
Kyriba's latest CIR unveils a $30bn FX impact on 1,200 multinational firms in Q3 2023, highlighting FX's influence on revenues and cash flows.
Intix a data management product company appoints Kurt Florus as their new CTO aiming to streamline transaction data processing.
The high content screening market will register positive growth, with the overall valuation forecast to reach US$1.6 billion in 2022, according to FMI.
Sandy Baker appointed independent non-executive director of Stanchion, brings 30+ years experience in finance, governance and impact investing.
Kaspersky launches comprehensive cybersecurity policy to address the security risks posed by human augmentation technology in the workplace.
2020 will go down in history for the year of the global pandemic, but also for the rise of innovative digital technologies.
Litmaps, a New Zealand AI tool, has expanded its growth to 370,000 global users, preparing for a Series A to expand its academic reach.
NZTech unveils a report outlining the crucial role technology may have in cutting emissions and promoting environmental sustainability.
Mary Alice Simon's appointment is intended to boost production, quality systems and New Zealand's first medicinal cannabis trials.
A waxworm’s gut microbes could help scientists devise ways to break down polyethylene, offering a possible route to curb mounting plastic pollution.
Insect bioconversion could turn millions of tonnes of food waste into animal feed, biodiesel and packaging materials, while cutting emissions.
Pragmatic solutions are needed to cut waste, trim compliance costs and keep safety goals intact as prescriptive rules prove too rigid.
New Zealand's medicinal cannabis sector gains a major research boost as Dr James Polston joins Helius after leading R&D at Trulieve.
With New Zealand aiming to make tech our number two export by 2025, and primary industry already our number one, we need a clear path forward.
Auckland billboards fronted by eight patients and advocates aim to reduce stigma as New Zealand's medicinal cannabis laws take shape.
.webp)
